IL-33 and soluble ST2 are higher in plasma samples from COPD patients compared to controls, and the frequency of IL-33 expressing peripheral blood lymphocytes and neutrophils as well as the expression of IL-33 in bronchial epithelial cells is increased in COPD patients [147]. This evidence concerns the gene IL33 and chronic obstructive pulmonary disease.